A case of pediatric PTLD following autologous stem cell transplantation and review of the literature

Authors


Haydar Frangoul, Department of Pediatric Hematology/Oncology, 323 PRB, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN 37232-6310, USA
Tel.: 615 936 1762
Fax: 615 936 1767
E-mail: haydar.frangoul@vanderbilt.edu

Abstract

Eckrich MJ, Frangoul H, Knight J, Mosse C, Domm J. A case of pediatric PTLD following autologous stem cell transplantation and review of the literature.
Pediatr Transplantation 2012: 16: E15–E18. © 2010 John Wiley & Sons A/S.

Abstract:  The development of PTLD is a rare severe adverse event following ASCT. We report on a child with DS who developed PTLD following autologous transplant for relapsed Hodgkin’s disease. He was successfully treated with cyclophosphamide, prednisone and rituximab. We also present a comprehensive review of the literature of PTLD in pediatric patients following ASCT.

Ancillary